| Prev Close | 168.26 |
| Day Low/High | 164.55 / 168.34 |
| 52 Wk Low/High | 134.19 / 181.72 |
| Avg Volume | 676.80K |
| Exchange | NYSE |
| Shares Outstanding | 102.00M |
| Market Cap | 17.16B |
| EPS | 12.40 |
| P/E Ratio | 13.78 |
| Div & Yield | N.A. (N.A) |
LabCorp® (NYSE: LH) announced today that for the period of March 12, 2018 to September 11, 2018, its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will accrue (subject to the terms of the Zero...
LabCorp® (NYSE: LH), a leading global life sciences company, announced today that its Covance Drug Development (Covance) business has formed a global immunology and immunotoxicology (I&I) unit dedicated to the...
LabCorp® (NYSE: LH) today announced it will participate at the 2018 Barclays Global Healthcare Conference.
As part of a community service campaign, an enthusiastic group of LabCorp employees teamed up with Cheeriodicals to assemble and deliver 128 big green boxes to children patients at Florida Hospital Memorial Medical Center...
LabCorp® (NYSE: LH), a leading global life sciences company, announced today that its Covance Drug Development (Covance) business has entered into a strategic technology agreement with GlaxoSmithKline plc (GSK).
LabCorp® (NYSE: LH) today announced it will participate at the 39th Annual Raymond James Institutional Investors Conference.
LabCorp® (NYSE: LH), a leading global life sciences company, will host an Investor and Analyst Day for institutional investors and financial analysts in New York City on Tuesday, February 27, 2018.
Centene and Laboratory Corp. of America were among the healthcare stocks in the green on Tuesday, Feb. 6, amid a volatile trading day in the stock market.
LabCorp ® (or the Company) (NYSE: LH) today announced results for the fourth quarter and year ended December 31, 2017, and provided 2018 guidance.
Laboratory Corporation of America ® Holdings (LabCorp) (NYSE: LH), a leading global life sciences company, today announced that it has been named to FORTUNE magazine's 2018 List of World's Most Admired Companies.
LabCorp® (NYSE: LH), a leading global life sciences company, announced today that its Covance Drug Development (Covance) business has introduced a dedicated offering for biotech, medical device and diagnostics...
LabCorp® (NYSE: LH) today announced it will participate at the 36th Annual J.
LabCorp ® (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below.
LabCorp (NYSE: LH), a leading global life sciences company, today issued the following statement regarding the lawsuit filed by the American Clinical Laboratory Association (ACLA) against the Acting Secretary of the U.
LabCorp (NYSE: LH) a leading global life sciences company, today announced the U.
LabCorp, (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, proudly announces that it received the 2017 Partnership Award from Be The Match® on November 11 at...
LabCorp (NYSE: LH), a leading global life sciences company, announced that it received a perfect score of 100 percent on the 2018 Corporate Equality Index (CEI), a national benchmarking survey and report on corporate...
LabCorp ® (NYSE: LH) today announced it will participate at the 26th Annual Credit Suisse Healthcare Conference.
LabCorp® (NYSE: LH), a leading global life sciences company, and Capital Health, the Central New Jersey/Lower Bucks County, Pennsylvania region's leader in providing progressive, quality patient care, announced today...
LabCorp ® (or the "Company") (NYSE: LH) today announced results for the third quarter ended September 30, 2017, and increased its 2017 guidance.
LabCorp (NYSE: LH), a leading global life sciences company, announced today that its Covance Drug Development business (Covance) has been awarded the 2017 Frost & Sullivan Asia Pacific CRO Customer Value Leadership...
LabCorp® (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below.
LabCorp (NYSE: LH), a leading global life sciences company, today issued the following response to the Sept.
LabCorp (NYSE: LH), a leading global life sciences company, announced today that Integrated Genetics, a member of the LabCorp Specialty Testing Group, is presenting the results of nine studies relating to prenatal testing,...
LabCorp® (NYSE: LH) announced today that for the period of September 11, 2017 to March 9, 2018, its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will, subject to the terms of the Zero Coupon...
LabCorp® (NYSE: LH), a leading global life sciences company, has been named to Forbes' 2017 ranking of "The World's Most Innovative Companies.
LabCorp® (NYSE:LH) today announced it will participate at the Morgan Stanley Global Healthcare Conference.
LabCorp® (NYSE: LH), a leading global life sciences company, has completed its previously announced acquisition of Chiltern, which will become part of the company's Covance Drug Development business.
